Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers
Condition(s):Renal Cancer; TumorsLast Updated:February 19, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Renal Cancer; TumorsLast Updated:February 19, 2014Completed
Condition(s):Neoplasms; Kidney Neoplasms; Urologic Neoplasms; Urogenital Neoplasms; Female Urogenital Diseases; Urogenital Diseases; Kidney Diseases; Urologic Diseases; Male Urogenital Diseases; Carcinoma; Carcinoma, Renal Cell; Antineoplastic Agents; Immune Checkpoint InhibitorsLast Updated:November 2, 2023Recruiting
Condition(s):Endometrial Cancer; Kidney Cancer; Ovarian Cancer; Pheochromocytoma; SarcomaLast Updated:August 8, 2014Completed
Condition(s):Breast CancerLast Updated:October 19, 2020Terminated
Condition(s):Melanoma; Lymph Node CancerLast Updated:January 9, 2024Completed
Condition(s):Renal Cell CarcinomaLast Updated:June 26, 2018Terminated
Condition(s):Kidney Cancer; Leukemia; Lymphoma; Neurotoxicity; Peripheral Neuropathy; SarcomaLast Updated:August 11, 2021Completed
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:September 17, 2015Terminated
Condition(s):Neoadjuvant Therapy; Advanced Cancer; Metastatic Kidney CancerLast Updated:May 13, 2020Unknown status
Condition(s):Renal Cell CancerLast Updated:April 11, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.